Qiaoshi Xu
Overview
Explore the profile of Qiaoshi Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng A, Xu Q, Li B, Zhang L, Wang H, Liu C, et al.
Cell Death Dis
. 2024 May;
15(5):376.
PMID: 38811531
The tumor margin as the invasive front has been proven to be closely related to the progression and metastasis of oral squamous cell carcinoma (OSCC). However, how tumor cells in...
2.
Xu Q, Cheng A, Li B, Tian X, Han Z, Feng Z
J Extracell Vesicles
. 2024 Mar;
13(4):e12427.
PMID: 38545803
The heterogeneity of tumour cells enables cancers to dynamically adapt to microenvironmental stresses during progression. However, the mechanism underlying the transformation and intercellular communication between heterogeneous tumour cells has remained...
3.
Xu Q, Li X
J Stomatol Oral Maxillofac Surg
. 2023 Dec;
125(4):101738.
PMID: 38097013
Head and neck squamous cell carcinoma (HNSCC) is considered a "cold tumor" due to its suppressive immune microenvironment, and is associated with a poor prognosis. Tumor-derived extracellular vesicles (EVs) play...
4.
Zhang L, Xu Q, Feng Z
Oral Oncol
. 2023 Nov;
148:106616.
PMID: 37988836
There is currently no comprehensive genome-wide description of the primary ghost cell odontogenic carcinoma (GCOC), hindering our understanding of pathogenesis. We herein present a case with comprehensive clinical, genome and...
5.
Xu Q, Zhang L, Li B, Cheng A, Wang C, Li D, et al.
Oral Dis
. 2023 Jul;
30(4):2219-2228.
PMID: 37455401
Background: The aim of this study was to determine the significance of elective neck dissection (END) for patients of different ages with T2N0M0 oral squamous cell carcinoma (OSCC) and sought...
6.
Zhang L, Xu Q, Liu H, Li B, Wang H, Liu C, et al.
Front Oncol
. 2022 Nov;
12:1017630.
PMID: 36387128
Objectives: The prognosis, choice of reconstruction and the quality of life (QOL) after salvage surgery (SS) for extensively locoregional recurrent/metastatic head and neck cancer (R/M HNC) is an important issue,...
7.
Li D, Niu Q, Wang C, Wei W, Li B, Liu H, et al.
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2022 Aug;
135(1):33-41.
PMID: 35985962
Objective: We aimed to validate and evaluate the comprehensive complication index (CCI) as a measure of postoperative complications (POCs) in the patients with head and neck squamous cell carcinoma (HNSCC)...
8.
Li B, Cheng A, Liu H, Wang H, Wang C, Xu Q, et al.
Oral Dis
. 2022 Aug;
29(7):2650-2657.
PMID: 35925052
Objective: The purpose of this study is to explore the effects of modified vermilion border-marionette line (MVBML) approach on postoperative facial scar, nerves injury, and prognosis of patients with buccal...
9.
Xiao R, Wu J, Ward B, Liu H, Li B, Wang C, et al.
Oral Dis
. 2022 May;
29(5):2066-2075.
PMID: 35579052
Objective: The purpose of this study was to investigate the prognostic value of the family history of cancer (FHC) in predicting survival and clinicopathological features in oral squamous cell carcinoma...
10.
Kang J, Su M, Xu Q, Wang C, Yuan X, Han Z
Oral Dis
. 2021 Aug;
29(2):628-638.
PMID: 34455659
Objective: The objectives of this study were to estimate the prognostic value of the tumour-stroma ratio (TSR) and tumour budding (TB) in oral tongue squamous cell carcinoma (OTSCC) and to...